TheraRadar
← Back
Data updated: Jul 17, 2026

MIZA PHARMS USA

Generics
Pharmaceuticals

MIZA PHARMS USA is a generic drug manufacturer with 3 FDA-approved products.

1972
Since
3
Drugs
-
Trials
0
New Drugs (2yr)

MIZA PHARMS USA's Key Drugs

MIZA PHARMS USA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

MIZA PHARMS USA's Recent FDA Approvals

New NDA/BLA approvals for MIZA PHARMS USA over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

MIZA PHARMS USA's Therapeutic Areas

Disease areas where MIZA PHARMS USA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

MIZA PHARMS USA Pipeline Snapshot

Active clinical trials for MIZA PHARMS USA across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling